CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

Establishing the diagnosis of focal brain lesions in patients with unexplained neurologic symptoms represents a challenge. The goal of this study is to provide evidence supporting functional roles for CXC chemokine ligand (CXCL)13 and interleukin (IL)-10 in central nervous system (CNS) lymphomas and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rubenstein, James L., Wong, Valerie S., Kadoch, Cigall, Gao, Hua-Xin, Barajas, Ramon, Chen, Lingjing, Josephson, S. Andrew, Scott, Brian, Douglas, Vanja, Maiti, Mekhala, Kaplan, Lawrence D., Treseler, Patrick A., Cha, Soonmee, Hwang, Jimmy H., Cinque, Paola, Cyster, Jason G., Lowell, Clifford
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2013
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674672/
https://ncbi.nlm.nih.gov/pubmed/23570798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-01-476333
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados